Taiga Biotechnologies, Inc. is a clinical stage biotechnology company focused on harnessing the power of the immune system to fight solid tumors and infectious disease and on improving blood stem cell transplantation

OUR MISSION

Developing treatments for the drug resistant world

 

OUR LEADERSHIP

Yosef Refaeli, Ph.D.

Chief Executive Officer

Co-Founder

Brian Turner, Ph.D.

President & Chief Scientific Officer

Co-Founder

James Kelly

Chief Financial Officer

Robert Gulock

Chief Commercial Officer

Samuel Brown, M.D.

Medical Director